Altshuler Shaham’s GSK GSK Stock Holding History

Altshuler Shaham’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,000	Closed	-$1.8M	–	381
2025 Q2	$1.8M	Sell	47,000 -10,000	-18%	-$382K	0.06%	56
2025 Q1	$2.21M	Hold	57,000	–	–	0.05%	42
2024 Q4	$1.93M	Buy	+57,000	New	+$2.05M	0.07%	33
2022 Q2	–	Sell	-2,960	Closed	-$161K	–	493
2022 Q1	$161K	Sell	2,960 -2,400	-45%	-$130K	﹤0.01%	239
2021 Q4	$256K	Hold	5,360	–	–	﹤0.01%	233
2021 Q3	$256K	Hold	5,360	–	–	﹤0.01%	232
2021 Q2	$267K	Hold	5,360	–	–	﹤0.01%	252
2021 Q1	$239K	Hold	5,360	–	–	﹤0.01%	191
2020 Q4	$247K	Buy	5,360 +672	+14%	+$30.9K	﹤0.01%	154
2020 Q3	$221K	Hold	4,688	–	–	0.01%	136
2020 Q2	$239K	Buy	4,688 +3,728	+388%	+$191K	0.01%	119
2020 Q1	$45K	Hold	960	–	–	﹤0.01%	192
2019 Q4	$56K	Hold	960	–	–	﹤0.01%	187
2019 Q3	$51K	Buy	+960	New	+$49.4K	﹤0.01%	184

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Altshuler Shaham's GSK Position: Q3 2025 in Review

Altshuler Shaham sold out of GSK (GSK) in Q3 2025, closing a stake of 47,000 shares — an estimated $1.8M sold.

Altshuler Shaham first reported a position in GSK in Q3 2019 and held it in 14 quarters. The position peaked at $2.21M in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Altshuler Shaham reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Altshuler Shaham sold 47,000 GSK shares in Q3 2025, an estimated $1.8M.
Altshuler Shaham first reported a position in GSK in Q3 2019 and held it in 14 quarters.
Altshuler Shaham's GSK position peaked at $2.21M in Q1 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Altshuler Shaham's 13F filing for Q3 2025, filed 13 Nov 2025.